University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Stephen McLeod, M.D.

Ophthalmologist

Dr. Stephen D. McLeod, chair of the Ophthalmology department at UCSF, specializes in refractive, or vision correction, surgery, cataract and corneal disease. In his research, he has focused on the development of an intraocular lens to restore near vision to patients undergoing cataract surgery.

McLeod earned a medical degree at Johns Hopkins University School of Medicine in Baltimore, Md. After completing an ophthalmology residency at the Illinois Eye and Ear Infirmary at the University of Illinois, Chicago, he completed fellowship training in cornea, external disease and refractive surgery at the University of Southern California's Doheny Eye Institute. He is chair of the American Academy of Ophthalmology's Preferred Practice Pattern (PPP) Panels and is a consultant to the Ophthalmic Devices Panel of the Food and Drug Administration (FDA). He is also editor of the American Medical Association's journal for ophthalmology research, JAMA Ophthalmology.

Clinics

Corneal Disease and Surgery
8 Koret Way, Suite U-545
San Francisco, CA 94143
Phone: (415) 514–8200
Fax: (415) 514–6845

Laser Vision Center
8 Koret Way, Room U-519
San Francisco, CA 94143–0644
Phone: (415) 353–2020
Fax: (415) 514–6892

Hours: Monday to Friday, 8 a.m. – 5 p.m.

Conditions & Treatments

More about Stephen McLeod

Education

Johns Hopkins School of Medicine 1989

Residencies

Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Ophthalmology 1993

Fellowships

USC Doheny Eye Institute, Cornea, External Eye Disease and Refractive Surgery 1994

Selected Research and Publications

  1. Prajna NV, Srinivasan M, Lalitha P, Krishnan T, Rajaraman R, Ravindran M, Mascarenhas J, Oldenburg CE, Ray KJ, McLeod SD, Acharya NR, Lietman TM. Differences in clinical outcomes in keratitis due to fungus and bacteria. JAMA Ophthalmol. 2013 Aug; 131(8):1088-9.
  2. Sun CQ, Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Srinivasan M, Raghavan A, O'Brien KS, Ray KJ, McLeod SD, Porco TC, Acharya NR, Lietman TM. Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I. Invest Ophthalmol Vis Sci. 2013 Jun; 54(6):4167-73.
  3. Seider MI, McLeod SD, Porco TC, Schallhorn SC. The effect of procedure room temperature and humidity on LASIK outcomes. Ophthalmology. 2013 Nov; 120(11):2204-8.
  4. Oldenburg CE, Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Borkar DS, Ray KJ, Zegans ME, McLeod SD, Porco TC, Lietman TM, Acharya NR. Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India. Ophthalmic Epidemiol. 2013 Jun; 20(3):155-8.
  5. Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan M, Raghavan A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Porco TC, Acharya NR, Lietman TM. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013 Apr; 131(4):422-9.
  6. Ray KJ, Prajna L, Srinivasan M, Geetha M, Karpagam R, Glidden D, Oldenburg CE, Sun CQ, McLeod SD, Acharya NR, Lietman TM. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmol. 2013 Mar; 131(3):310-3.
  7. Borkar DS, Fleiszig SM, Leong C, Lalitha P, Srinivasan M, Ghanekar AA, Tam C, Li WY, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis. JAMA Ophthalmol. 2013 Feb; 131(2):147-53.
  8. See CW, Srinivasan M, Saravanan S, Oldenburg CE, Esterberg EJ, Ray KJ, Glaser TS, Tu EY, Zegans ME, McLeod SD, Acharya NR, Lietman TM. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiol. 2012 Dec; 19(6):407-13.
  9. Lin CC, Lalitha P, Srinivasan M, Prajna NV, McLeod SD, Acharya NR, Lietman TM, Porco TC. Seasonal trends of microbial keratitis in South India. Cornea. 2012 Oct; 31(10):1123-7.
  10. Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Priya JL, Sy A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Nocardia keratitis: clinical course and effect of corticosteroids. Am J Ophthalmol. 2012 Dec; 154(6):934-939.e1.
  11. Sy A, McLeod SD, Cohen EJ, Margolis TP, Mannis MJ, Lietman TM, Acharya NR. Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus. Cornea. 2012 Jul; 31(7):786-90.
  12. Prajna NV, Krishnan T, Mascarenhas J, Srinivasan M, Oldenburg CE, Toutain-Kidd CM, Sy A, McLeod SD, Zegans ME, Acharya NR, Lietman TM, Porco TC. Predictors of outcome in fungal keratitis. Eye (Lond). 2012 Sep; 26(9):1226-31.
  13. Gilmer W, McLeod SD, Jeng BH. Laboratory model of bursting pressures of femtosecond laser-assisted penetrating keratoplasty wounds using novel pattern designs. Br J Ophthalmol. 2012 Sep; 96(9):1273-4.
  14. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Glidden D, Oldenburg CE, Whitcher JP, Zegans ME, McLeod SD, Lietman TM, Acharya NR, Steroids For Corneal Ulcers Trial Group FT. Subgroup analysis in the steroids for corneal ulcers trial-reply. Arch Ophthalmol. 2012 Jun 1; 130(6):807-8.
  15. Lalitha P, Prajna NV, Oldenburg CE, Srinivasan M, Krishnan T, Mascarenhas J, Vaitilingam CM, McLeod SD, Zegans ME, Porco TC, Acharya NR, Lietman TM. Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial. Cornea. 2012 Jun; 31(6):662-7.
  16. Dalmon C, Porco TC, Lietman TM, Prajna NV, Prajna L, Das MR, Kumar JA, Mascarenhas J, Margolis TP, Whitcher JP, Jeng BH, Keenan JD, Chan MF, McLeod SD, Acharya NR. The clinical differentiation of bacterial and fungal keratitis: a photographic survey. Invest Ophthalmol Vis Sci. 2012 Apr; 53(4):1787-91.
  17. Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Cevallos V, Oldenburg CE, Ray KJ, Toutain-Kidd CM, Glidden DV, Zegans ME, McLeod SD, Acharya NR, Lietman TM. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clin Infect Dis. 2012 May; 54(10):1381-7.
  18. Lalitha P, Lin CC, Srinivasan M, Mascarenhas J, Prajna NV, Keenan JD, McLeod SD, Acharya NR, Lietman TM, Porco TC. Acanthamoeba keratitis in South India: a longitudinal analysis of epidemics. Ophthalmic Epidemiol. 2012 Apr; 19(2):111-5.
  19. Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, Oldenburg CE, Ray KJ, Glidden D, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Invest Ophthalmol Vis Sci. 2012 Jan; 53(1):267-72.
  20. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012 Feb; 130(2):143-50.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.